8/21/2013 6:46:28 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
In a laboratory, preclinical study recently published by the journal Organic & Biomolecular Chemistry, Virginia Commonwealth University Massey Cancer Center researchers combined structural features from anti-nausea drug thalidomide with common kitchen spice turmeric to create hybrid molecules that effectively kill multiple myeloma cells. Thalidomide was first introduced in the 1950s as an anti-nausea medication to help control morning sickness, but was later taken off the shelves in 1962 because it was found to cause birth defects.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by